Your browser doesn't support javascript.
loading
Identification and Characterization of Synaptic Vesicle Membrane Protein VAT-1 Homolog as a New Catechin-Binding Protein.
Ikemizu, Ayaka; Hatta, Daisuke; Fujimoto, Kohei; Honda, Mikako; Watanabe, Kaori; Ohyama, Kaname; Kuroda, Naotaka; Tanaka, Takashi; Shirotani, Keiro; Iwata, Nobuhisa.
Afiliación
  • Ikemizu A; Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
  • Hatta D; Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
  • Fujimoto K; Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
  • Honda M; Faculty of Pharmaceutical Sciences, Nagasaki University.
  • Watanabe K; Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
  • Ohyama K; Department of Hospital Pharmacy, Nagasaki University Hospital.
  • Kuroda N; Department of Analytical Chemistry for Pharmaceuticals, Graduate School of Biomedical Sciences, Nagasaki University.
  • Tanaka T; Department of Natural Product Chemistry, Graduate School of Biomedical Sciences, Nagasaki University.
  • Shirotani K; Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University.
  • Iwata N; Faculty of Pharmaceutical Sciences, Nagasaki University.
Biol Pharm Bull ; 47(2): 509-517, 2024.
Article en En | MEDLINE | ID: mdl-38403661
ABSTRACT
(-)-Epigallocatechin-3-gallate (EGCg), a major constituent of green tea extract, is well-known to exhibit many beneficial actions for human health by interacting with numerous proteins. In this study we identified synaptic vesicle membrane protein VAT-1 homolog (VAT1) as a novel EGCg-binding protein in human neuroglioma cell extracts using a magnetic pull-down assay and LC-tandem mass spectrometry. We prepared recombinant human VAT1 and analyzed its direct binding to EGCg and its alkylated derivatives using surface plasmon resonance. For EGCg and the derivative NUP-15, we measured an association constant of 0.02-0.85 ×103 M-1s-1 and a dissociation constant of nearly 8 × 10-4 s-1. The affinity Km(affinity) of their binding to VAT1 was in the 10-20 µM range and comparable with that of other EGCg-binding proteins reported previously. Based on the common structure of the compounds, VAT1 appeared to recognize a catechol or pyrogallol moiety around the B-, C- and G-rings of EGCg. Next, we examined whether VAT1 mediates the effects of EGCg and NUP-15 on expression of neprilysin (NEP). Treatments of mock cells with these compounds upregulated NEP, as observed previously, whereas no effect was observed in the VAT1-overexpressing cells, indicating that VAT1 prevented the effects of EGCg or NUP-15 by binding to and inactivating them in the cells overexpressing VAT1. Further investigation is required to determine the biological significance of the VAT1-EGCg interaction.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Catequina / Proteínas de Transporte Vesicular Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Catequina / Proteínas de Transporte Vesicular Límite: Humans Idioma: En Revista: Biol Pharm Bull Asunto de la revista: BIOQUIMICA / FARMACOLOGIA Año: 2024 Tipo del documento: Article